Structural and electrical remodeling as therapeutic targets in heart failure

被引：16
作者：
Cutler, Michael J.
Rosenbaum, David S.
Dunlap, Mark E.
机构：
[1] Heart and Vascular Research Center, Case Western Reserve University, Cleveland, OH, MetroHealth Campus
来源：
JOURNAL OF ELECTROCARDIOLOGY | 2007年 / 40卷 / 06期
关键词：
D O I：
10.1016/j.jelectrocard.2007.05.027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Heart failure is a progressive clinical syndrome that is characterized by remodeling of the myocardium in response to various stress signals. The past several years has seen remarkable progress in unraveling the molecular and cellular mechanisms of structural and electrical remodeling in HE Improved understanding of the molecular mechanism of myocardial remodeling has resulted in improved HF therapies and revealed potentially novel therapeutic targets. This review discusses the mechanisms of myocardial remodeling in HF and their clinical manifestations. Current and investigational HF therapies targeting these mechanisms also will be discussed. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码：S1 / S7
页数：7
相关论文
共 50 条
[41]   Reverse remodeling in heart failure-mechanisms and therapeutic opportunities [J].
Koitabashi, Norimichi ;
Kass, David A. .
NATURE REVIEWS CARDIOLOGY, 2012, 9 (03) :147-157
[42]   Implication of cardiac remodeling in heart failure: Mechanisms and therapeutic strategies [J].
Takano, H ;
Hasegawa, H ;
Nagai, T ;
Komuro, I .
INTERNAL MEDICINE, 2003, 42 (06) :465-469
[43]   Geroscience in heart failure: the search for therapeutic targets in the shared pathobiology of human aging and heart failure [J].
Castro, Claire ;
Delwarde, Constance ;
Shi, Yanxi ;
Roh, Jason .
JOURNAL OF CARDIOVASCULAR AGING, 2025, 5 (01)
[44]   The Role of Mitochondrial Dysfunction in Heart Failure and Potential Therapeutic Targets [J].
Banovic, Marko D. ;
Ristic, Arsen D. .
CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (31) :4752-4762
[45]   Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure [J].
Tousoulis, D ;
Charakida, M ;
Stefanadis, C .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 100 (03) :347-353
[46]   Anemia and Iron Deficiency -- New Therapeutic Targets in Heart Failure?. [J].
Dec, G. William .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25) :2475-2477
[47]   Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets [J].
Reina-Couto, Marta ;
Pereira-Terra, Patricia ;
Quelhas-Santos, Janete ;
Silva-Pereira, Carolina ;
Albino-Teixeira, Antonio ;
Sousa, Teresa .
FRONTIERS IN PHYSIOLOGY, 2021, 12
[48]   Using Omics to Identify Novel Therapeutic Targets in Heart Failure [J].
Lteif, Christelle ;
Huang, Yimei ;
Guerra, Leonardo A. ;
Gawronski, Brian E. ;
Duarte, Julio D. .
CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2024, 17 (03) :277-293
[49]   Emerging therapeutic targets in chronic heart failure:: Part II [J].
Roenicke, V ;
Leclair, S ;
Hoffmann, A ;
Becker, M ;
Szado, T ;
Kirsch, T ;
Stoss, O ;
Navé, BT ;
Henkel, T .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (01) :49-59
[50]   Crosstalk of the heart and periphery: Skeletal and cardiac muscle as therapeutic targets in heart failure [J].
Gordon, A ;
VoipioPulkki, LM .
ANNALS OF MEDICINE, 1997, 29 (04) :327-331
12345